New Recombinant Mpox Strain Found in UK
Analysis based on 10 articles · First reported Dec 08, 2025 · Last updated Dec 09, 2025
The discovery of a new recombinant mpox strain by United Kingdom — UK Health Security Agency could lead to increased demand for vaccines and antiviral treatments, potentially benefiting pharmaceutical and biotechnology companies. However, it also introduces uncertainty regarding future public health measures and economic activity if the strain proves more transmissible or virulent.
Health officials in the United Kingdom, specifically the United Kingdom — UK Health Security Agency, have identified a new 'hybrid' or 'recombinant' strain of the mpox virus. This strain contains genetic material from two different mpox clades, Ib and IIb, which are currently circulating globally. The discovery was made in an individual who had recently traveled to Asia. Experts from Emory University School of Medicine and the University of Oxford have expressed concerns that this development is precisely what was feared if the virus continued to spread unchecked, potentially altering its transmissibility or virulence. The United Kingdom — UK Health Security Agency is currently assessing the significance of this finding and has alerted the World Health Organization. The United Kingdom — National Health Service continues to offer mpox vaccinations to eligible groups in the United Kingdom, emphasizing the vaccine's effectiveness in preventing severe disease.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard